RGEN Q2 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$32M+11.3% YoY

Gross Profit

$19M57.1% margin

Operating Income

$5M16.9% margin

Net Income

$8M26.0% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$309M

Total Liabilities

$118M

Stockholders' Equity

$191M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$29M	+11.3%
Gross Profit	$19M	$17M	+12.1%
Operating Income	$5M	$6M	-6.6%
Net Income	$8M	$4M	+117.9%